Raza A - Search Results

1

Survey and evaluation of mutations in the human KLF1 transcription unit.

Gnanapragasam MN, Crispino JD, Ali AM, Weinberg R, Hoffman R, Raza A, Bieker JJ. Gnanapragasam MN, et al. Among authors: raza a. Sci Rep. 2018 Apr 26;8(1):6587. doi: 10.1038/s41598-018-24962-3. Sci Rep. 2018. PMID: 29700354 Free PMC article.

2

Disease-associated mutation in SRSF2 misregulates splicing by altering RNA-binding affinities.

Zhang J, Lieu YK, Ali AM, Penson A, Reggio KS, Rabadan R, Raza A, Mukherjee S, Manley JL. Zhang J, et al. Among authors: raza a. Proc Natl Acad Sci U S A. 2015 Aug 25;112(34):E4726-34. doi: 10.1073/pnas.1514105112. Epub 2015 Aug 10. Proc Natl Acad Sci U S A. 2015. PMID: 26261309 Free PMC article.

3

U2AF35(S34F) Promotes Transformation by Directing Aberrant ATG7 Pre-mRNA 3' End Formation.

Park SM, Ou J, Chamberlain L, Simone TM, Yang H, Virbasius CM, Ali AM, Zhu LJ, Mukherjee S, Raza A, Green MR. Park SM, et al. Among authors: raza a. Mol Cell. 2016 May 19;62(4):479-90. doi: 10.1016/j.molcel.2016.04.011. Epub 2016 May 12. Mol Cell. 2016. PMID: 27184077 Free PMC article.

4

Physiologic Expression of Sf3b1(K700E) Causes Impaired Erythropoiesis, Aberrant Splicing, and Sensitivity to Therapeutic Spliceosome Modulation.

Obeng EA, Chappell RJ, Seiler M, Chen MC, Campagna DR, Schmidt PJ, Schneider RK, Lord AM, Wang L, Gambe RG, McConkey ME, Ali AM, Raza A, Yu L, Buonamici S, Smith PG, Mullally A, Wu CJ, Fleming MD, Ebert BL. Obeng EA, et al. Among authors: raza a. Cancer Cell. 2016 Sep 12;30(3):404-417. doi: 10.1016/j.ccell.2016.08.006. Cancer Cell. 2016. PMID: 27622333 Free PMC article.

5

Two different "tales" of ATG7: Clinical relevance to myelodysplastic syndromes.

Ali AM, Raza A. Ali AM, et al. Among authors: raza a. Mol Cell Oncol. 2016 Jul 26;3(5):e1212686. doi: 10.1080/23723556.2016.1212686. eCollection 2016. Mol Cell Oncol. 2016. PMID: 27857975 Free PMC article.

6

Severely impaired terminal erythroid differentiation as an independent prognostic marker in myelodysplastic syndromes.

Ali AM, Huang Y, Pinheiro RF, Xue F, Hu J, Iverson N, Hoehn D, Coutinho D, Kayani J, Chernak B, Lane J, Hillyer C, Galili N, Jurcic J, Mohandas N, An X, Raza A. Ali AM, et al. Among authors: raza a. Blood Adv. 2018 Jun 26;2(12):1393-1402. doi: 10.1182/bloodadvances.2018018440. Blood Adv. 2018. PMID: 29903708 Free PMC article.

7

Improving Treatment for Myelodysplastic Syndromes Patients.

Montoro J, Yerlikaya A, Ali A, Raza A. Montoro J, et al. Among authors: raza a. Curr Treat Options Oncol. 2018 Oct 25;19(12):66. doi: 10.1007/s11864-018-0583-4. Curr Treat Options Oncol. 2018. PMID: 30362079 Review.

8

Gene-edited stem cells enable CD33-directed immune therapy for myeloid malignancies.

Borot F, Wang H, Ma Y, Jafarov T, Raza A, Ali AM, Mukherjee S. Borot F, et al. Among authors: raza a. Proc Natl Acad Sci U S A. 2019 Jun 11;116(24):11978-11987. doi: 10.1073/pnas.1819992116. Epub 2019 May 28. Proc Natl Acad Sci U S A. 2019. PMID: 31138698 Free PMC article.

9

Disease-Causing Mutations in SF3B1 Alter Splicing by Disrupting Interaction with SUGP1.

Zhang J, Ali AM, Lieu YK, Liu Z, Gao J, Rabadan R, Raza A, Mukherjee S, Manley JL. Zhang J, et al. Among authors: raza a. Mol Cell. 2019 Oct 3;76(1):82-95.e7. doi: 10.1016/j.molcel.2019.07.017. Epub 2019 Aug 29. Mol Cell. 2019. PMID: 31474574 Free PMC article.

10

Rewriting the rules for care of MDS and AML patients in the time of COVID-19.

Raza A, Assal A, Ali AM, Jurcic JG. Raza A, et al. Leuk Res Rep. 2020 Apr 20;13:100201. doi: 10.1016/j.lrr.2020.100201. eCollection 2020. Leuk Res Rep. 2020. PMID: 32318330 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,665 results

Search Page